General Information of the Compound
Compound ID
CP0551217
Compound Name
US10117858, Example 5
    Show/Hide
Synonyms
(S)-3-Amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide
1334546-77-8
2-Pyridinecarboxamide, 3-amino-6-methoxy-N-((2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)-
2-pyridinecarboxamide, 3-amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-
3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide
3-amino-6-methoxy-5-trifluoromethyl-pyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methyl-propyl)-amide
3-amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)pyridine-2-carboxamide
AKOS040759841
AMB0BO0WFH
BDBM297402
CHEMBL4650318
CS-0116371
DTXSID601336884
GTPL11547
HY-109177
Icenticaftor
Icenticaftor [INN]
Icenticaftor [USAN:INN]
Icenticaftor [USAN]
MS-25717
QBW-251
QBW251
Qbw251
SCHEMBL2372751
UNII-AMB0BO0WFH
US10117858, Example 5
WHO 11246
compound 33 [PMID: 34028270]
    Show/Hide
Structure
Formula
C12H13F6N3O3
Molecular Weight
361.242
Canonical SMILES
COc1nc(C(=O)NC[C@](C)(O)C(F)(F)F)c(N)cc1C(F)(F)F
    Show/Hide
InChI
InChI=1S/C12H13F6N3O3/c1-10(23,12(16,17)18)4-20-8(22)7-6(19)3-5(11(13,14)15)9(21-7)24-2/h3,23H,4,19H2,1-2H3,(H,20,22)/t10-/m0/s1
    Show/Hide
InChIKey
USHQRIKZLHNPQR-JTQLQIEISA-N
CAS
1334546-77-8
Physicochemical Property
logP
1.7343
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
97.47
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 58442344
ChEMBL ID
CHEMBL4650318
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000805 HBE1 Homo sapiens (Human)  2
1
EC50 = 39 nM
   TI
   LI
   LO
   TS
2
EC50 = 72 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
EC50 = 47 nM
   TI
   LI
   LO
   TS
CL000259 FRT Rattus norvegicus (Rat)  3
1
EC50 = 79 nM
   TI
   LI
   LO
   TS
2
EC50 = 113 nM
   TI
   LI
   LO
   TS
3
EC50 = 497 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( QBW251 )
Drug Name QBW251
Company Novartis Pharmaceuticals
Indication
Chronic obstructive pulmonary disease
Phase 2
Target(s)
cAMP-dependent chloride channel (CFTR)
Potentiator